Korean Drug Correlations
| 014570 Stock | KRW 4,600 75.00 1.60% |
The current 90-days correlation between Korean Drug and Formetal Co is 0.03 (i.e., Significant diversification). The correlation of Korean Drug is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Korean Drug Correlation With Market
Average diversification
The correlation between Korean Drug Co and DJI is 0.13 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Korean Drug Co and DJI in the same portfolio, assuming nothing else is changed.
Korean |
The ability to find closely correlated positions to Korean Drug could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Korean Drug when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Korean Drug - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Korean Drug Co to buy it.
Moving together with Korean Stock
Moving against Korean Stock
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Korean Stock performing well and Korean Drug Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Korean Drug's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 119500 | 3.24 | 0.23 | 0.08 | 0.55 | 3.35 | 8.77 | 25.31 | |||
| 017890 | 0.73 | 0.34 | 0.46 | 1.72 | 0.38 | 2.50 | 5.36 | |||
| 100220 | 1.67 | 0.21 | 0.12 | 0.42 | 1.73 | 3.90 | 23.83 | |||
| 000390 | 1.06 | 0.11 | 0.10 | 0.28 | 1.37 | 1.83 | 6.18 | |||
| 005830 | 1.49 | (0.12) | 0.00 | 0.17 | 0.00 | 3.85 | 12.50 | |||
| 090370 | 1.53 | 0.24 | 0.13 | 0.78 | 1.96 | 3.83 | 10.14 | |||
| 024110 | 0.68 | 0.13 | 0.24 | (1.63) | 0.67 | 1.54 | 5.50 | |||
| 036000 | 3.08 | 0.55 | 0.22 | (7.76) | 2.49 | 10.25 | 26.10 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Korean Drug without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Theme Ratings Now
Theme RatingsDetermine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Korean Drug Corporate Management
Elected by the shareholders, the Korean Drug's board of directors comprises two types of representatives: Korean Drug inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Korean. The board's role is to monitor Korean Drug's management team and ensure that shareholders' interests are well served. Korean Drug's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Korean Drug's outside directors are responsible for providing unbiased perspectives on the board's policies.
| SangHoon Park | Chief Director | Profile | |
| KyungDeuk Lee | Managing Director | Profile | |
| SeungGwon Baek | Managing Director | Profile | |
| KiPyung Lee | Managing Director | Profile | |
| Hai Park | Chief Chairperson | Profile | |
| HeeCheon Tak | Managing Director | Profile |